1-8 of 8
Masahiro Fukuoka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells

Tsutomu Iwasa, Isamu Okamoto, Minoru Suzuki, Erina Hatashita, Yuki Yamada, Masahiro Fukuoka, Koji Ono, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5117–5125.
https://doi.org/10.1158/1078-0432.CCR-09-0478
Published: 12 August 2009
View article titled, Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells
Open the PDF for Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations

Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4493–4498.
https://doi.org/10.1158/1078-0432.CCR-09-0391
Published: 01 July 2009
View article titled, Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <em>EGFR</em> Mutations
Open the PDF for Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <em>EGFR</em> Mutations in another window
Journal Articles

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

Taroh Satoh, Isamu Okamoto, Masaki Miyazaki, Ryotaroh Morinaga, Asuka Tsuya, Yoshikazu Hasegawa, Masaaki Terashima, Shinya Ueda, Masahiro Fukuoka, Yutaka Ariyoshi, Toshikazu Saito, Noriyuki Masuda, Hirokazu Watanabe, Tetsuo Taguchi, Toru Kakihara, Yumiko Aoyama, Yohko Hashimoto, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3872–3880.
https://doi.org/10.1158/1078-0432.CCR-08-1946
Published: 01 June 2009
View article titled, Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors in another window
Journal Articles

Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non–small cell Lung Cancer Cell Lines with MET Amplification

Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka, Junji Uchida, Erina Hatashita, Yuki Yamada, Takeshi Yoshida, Kazuto Nishio, Masahiro Fukuoka, Pasi A. Jänne, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 907–913.
https://doi.org/10.1158/1078-0432.CCR-08-2251
Published: 02 February 2009
View article titled, Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non–small cell Lung Cancer Cell Lines with <em>MET</em> Amplification
Open the PDF for Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non–small cell Lung Cancer Cell Lines with <em>MET</em> Amplification in another window
Journal Articles

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines

Tsutomu Iwasa, Isamu Okamoto, Minoru Suzuki, Takahito Nakahara, Kentaro Yamanaka, Erina Hatashita, Yuki Yamada, Masahiro Fukuoka, Koji Ono, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6496–6504.
https://doi.org/10.1158/1078-0432.CCR-08-0468
Published: 16 October 2008
View article titled, Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines
Open the PDF for Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines in another window
Journal Articles

Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non–Small Cell Lung Cancer: West Japan Thoracic Oncology Group 3505

Isamu Okamoto, Takashi Nishimura, Masaki Miyazaki, Hiroshige Yoshioka, Akihito Kubo, Koji Takeda, Noriyuki Ebi, Shunichi Sugawara, Nobuyuki Katakami, Masahiro Fukuoka, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5250–5254.
https://doi.org/10.1158/1078-0432.CCR-08-0511
Published: 12 August 2008
View article titled, Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non–Small Cell Lung Cancer: West Japan Thoracic Oncology Group 3505
Open the PDF for Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non–Small Cell Lung Cancer: West Japan Thoracic Oncology Group 3505 in another window
Journal Articles

Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer

Yuichiro Ohe, Yukito Ichinose, Kazuhiko Nakagawa, Tomohide Tamura, Kaoru Kubota, Nobuyuki Yamamoto, Susumu Adachi, Yoshihiro Nambu, Toshio Fujimoto, Yutaka Nishiwaki, Nagahiro Saijo, Masahiro Fukuoka
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4206–4212.
https://doi.org/10.1158/1078-0432.CCR-07-5143
Published: 01 July 2008
View article titled, Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B<sub>12</sub> in Previously Treated Patients with Non-Small Cell Lung Cancer
Open the PDF for Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B<sub>12</sub> in Previously Treated Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule

Noriyuki Masuda, Kaoru Matsui, Nobuyuki Yamamoto, Toshiji Nogami, Kazuhiko Nakagawa, Shunichi Negoro, Kouji Takeda, Nobuhide Takifuji, Masaji Yamada, Shinzoh Kudoh, Teruyoshi Okuda, Shinjiroh Nemoto, Kanako Ogawa, Hiroshi Myobudani, Shinichi Nihira, Masahiro Fukuoka
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2288–2294.
Published: 01 June 2000
View article titled, Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule
Open the PDF for Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule in another window